跳至主要内容
临床试验/JPRN-jRCTs042210010
JPRN-jRCTs042210010招募中未知

Study of the impact of the Flash Glucose Monitoring System (FGM) on glycometabolism of newly diagnosed type 2 diabetic patients

Arima Hiroshi0 个研究点目标入组 60 人开始时间: 2021年4月21日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
Arima Hiroshi
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Diabetes patients who
  • 1)are diagnosed type 2 diabetes mellitus
  • 2)have HbA1c level of 7.0% or more and less than 8.0%
  • 3)are 20 years of age or older
  • 4) are not prescribed any hypoglycemic drug

排除标准

  • Those who have hyperglycaemic symptoms or ketosis
  • Those whose anti-GAD Abs are positive
  • Those who have been using self-monitaring of blood glucose
  • THose who have preproliferative or proliferative diabetic retinopathy
  • Those who have severe renal failure (eGFR<30/ml/min/1.73m3)
  • Those who are judged by their physicians to be unsuitable for enrolling the study

研究者

发起方
Arima Hiroshi

相似试验